Skip to content
MedsAcross

Medicine

Carvedilol 3.125 mg tablet

Carvedilol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Carvedilol 3.125 mg tablet is a generic prescription medicine for oral use, made by 26 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F). Protect from moisture.

Key facts

Active ingredient (INN)
Carvedilol
Brand
Sold under the generic name
Strength
3.125 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 28 tablets and 99 more
Manufacturers
Zydus LifesciencesIndiaDr. Reddy's LaboratoriesIndiaGlenmark PharmaceuticalsIndiaAurobindo PharmaIndiaUnichem LaboratoriesIndiaAdvagen PharmaA-S Medication SolutionsBryant Ranch PrepackMethod PharmaceuticalsTeva Pharmaceuticals26 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C07AG02 Carvedilol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 September 2007
Identifiers
RxCUI 686924, 200031, 200032 +1DailyMed set ID add1ee3d-fca4-4301-b871-7dda6eda7bb7, fe2d5c95-c101-4b01-89fd-0fd6d25ad80b, f2a0407c-2e05-60eb-e053-2a95a90abc99 +37NDC 50090-6949, 50090-7890, 51655-034 +37Application ANDA077614, ANDA076373, ANDA078332 +5

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 26 labelers. The register lists 102 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle65841-616-01Zydus LifesciencesIndia5 September 2007
500 tablet, film coated in 1 bottle65841-616-05Zydus LifesciencesIndia5 September 2007
28 tablet, film coated in 1 bottle65841-616-17Zydus LifesciencesIndia5 September 2007
100 tablet, film coated in 1 bottle68382-092-01Zydus LifesciencesIndia5 September 2007
500 tablet, film coated in 1 bottle68382-092-05Zydus LifesciencesIndia5 September 2007
28 tablet, film coated in 1 bottle68382-092-17Zydus LifesciencesIndia5 September 2007
100 tablet, film coated in 1 bottle65862-142-01Aurobindo PharmaIndia5 September 2007
500 tablet, film coated in 1 bottle65862-142-05Aurobindo PharmaIndia5 September 2007
1000 tablet, film coated in 1 bottle65862-142-99Aurobindo PharmaIndia5 September 2007
100 tablet, film coated in 1 bottle55111-252-01Dr. Reddy's LaboratoriesIndia5 September 2007
500 tablet, film coated in 1 bottle55111-252-05Dr. Reddy's LaboratoriesIndia5 September 2007
1000 tablet, film coated in 1 bottle55111-252-10Dr. Reddy's LaboratoriesIndia5 September 2007
30 tablet, film coated in 1 bottle55111-252-30Dr. Reddy's LaboratoriesIndia5 September 2007
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack55111-252-78Dr. Reddy's LaboratoriesIndia5 September 2007
100 tablet, film coated in 1 bottle68462-162-01Glenmark PharmaceuticalsIndia5 September 2007
500 tablet, film coated in 1 bottle68462-162-05Glenmark PharmaceuticalsIndia5 September 2007
1000 tablet, film coated in 1 bottle68462-162-10Glenmark PharmaceuticalsIndia5 September 2007
180 tablet, film coated in 1 bottle68462-162-18Glenmark PharmaceuticalsIndia10 December 2014
60 tablet, film coated in 1 bottle68462-162-60Glenmark PharmaceuticalsIndia5 September 2007
100 tablet, film coated in 1 bottle, plastic76385-110-01Unichem LaboratoriesIndia1 October 2016
500 tablet, film coated in 1 bottle, plastic76385-110-50Unichem LaboratoriesIndia1 October 2016
1000 tablet, film coated in 1 bottle72888-034-00Advagen Pharma29 July 2021
100 tablet, film coated in 1 bottle72888-034-01Advagen Pharma29 July 2021
500 tablet, film coated in 1 bottle72888-034-05Advagen Pharma29 July 2021
30 tablet, film coated in 1 bottle72888-034-30Advagen Pharma29 July 2021
100 tablet, film coated in 1 bottle, plastic72888-499-01Advagen Pharma17 September 2025
500 tablet, film coated in 1 bottle, plastic72888-499-02Advagen Pharma17 September 2025
1000 tablet, film coated in 1 bottle, plastic72888-499-03Advagen Pharma17 September 2025
100 tablet, film coated in 1 bottle, plastic58657-750-01Method Pharmaceuticals3 December 2024
500 tablet, film coated in 1 bottle, plastic58657-750-50Method Pharmaceuticals3 December 2024
100 tablet, film coated in 1 bottle0093-0051-01Teva Pharmaceuticals6 September 2007
500 tablet, film coated in 1 bottle0093-0051-05Teva Pharmaceuticals2 December 2008
60 tablet, film coated in 1 bottle50090-1062-0A-S Medication Solutions28 November 2014
180 tablet, film coated in 1 bottle50090-1062-1A-S Medication Solutions28 November 2014
30 tablet, film coated in 1 bottle50090-1062-2A-S Medication Solutions28 November 2014
90 tablet, film coated in 1 bottle50090-1062-3A-S Medication Solutions28 November 2023
90 tablet, film coated in 1 bottle50090-6949-0A-S Medication Solutions18 December 2023
90 tablet, film coated in 1 bottle50090-7890-0A-S Medication Solutions9 February 2026
30 tablet, film coated in 1 bottle63629-4060-1Bryant Ranch Prepack27 August 2009
100 tablet, film coated in 1 bottle63629-4060-2Bryant Ranch Prepack4 September 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 September 1995Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Carvedilol 3.125 mg tablet.

Compare 1

Other strengths and forms of Carvedilol

Clinical summary

Carvedilol is an alpha-adrenergic blocker. It is available as tablets and extended-release capsules for oral use. MedsAcross supplies Carvedilol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Carvedilol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Carvedilol 3.125 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.